News
![Form 8.3 - The Vanguard Group, Inc.: Avast plc](/assets/news/news5-af8c677c86bb4b693f58afef33877e6f798ff0d7e2b4fa69b6e89960549b5ee6.png)
Form 8.3 - The Vanguard Group, Inc.: Avast plc
![The Buckle, Inc. Reports June 2022 Net Sales: https://mms.businesswire.com/media/20191107005107/en/222882/5/buckle-logo_hex.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBd0FqRUE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--a4599bfa987bbc36dd8fd9edd274659117c8cb17/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/buckle-logo_hex.jpg?locale=us)
The Buckle, Inc. Reports June 2022 Net Sales
The Buckle, Inc. (NYSE: BKE) announced today that comparable store net sales, for stores open at least one year, for the 5-week period ended July 2, 2022 decreased 1.7 percent from comparable store
![BitNile Holdings’ Subsidiary Ault Alliance Does Not Acquire EYP: https://mms.businesswire.com/media/20220512005443/en/1267458/5/Bitnile_Logo_%28300ppi%29.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNFYzV0E9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--a7aeaf571405e3bfd1320d7e8c956bc4d6f11368/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Bitnile_Logo_-28300ppi-29.jpg?locale=us)
BitNile Holdings’ Subsidiary Ault Alliance Does Not Acquire EYP
BitNile Holdings, Inc. (NYSE American: NILE), a diversified holding company (“BitNile” or the “Company”) announced today that its subsidiary, Ault Alliance, Inc. (“Ault Alliance”), did not acquire
![Chelverton UK Dividend Trust plc: Net Asset Value(s)](/assets/news/news8-29d1d55c755b03e328399113b5bdd004223f995e95194ba5ee80af9da39a41e3.png)
Chelverton UK Dividend Trust plc: Net Asset Value(s)
![QIAGEN N.V. to Release Results for Q2 2022 and Hold Webcast](/assets/news/news18-f135f6c168ef56d2b112890081403b0a310104acfadbf4a8f72634bd390e98ac.png)
QIAGEN N.V. to Release Results for Q2 2022 and Hold Webcast
QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced its plans to release results for the second quarter of 2022.
Press release date / time: Wednesday, July 27, shortly after 22:05
![Sensirion Connected Solutions AG: Continuous methane emissions monitoring solution for the energy industry](/assets/news/news18-f135f6c168ef56d2b112890081403b0a310104acfadbf4a8f72634bd390e98ac.png)
Sensirion Connected Solutions AG: Continuous methane emissions monitoring solution for the energy industry
![Americans are Delaying Non-Emergency Medical Care in Higher Numbers than Last Year: https://mms.businesswire.com/media/20191118005067/en/756953/5/Discover_NHL_092019v2_lock_up_2020.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNDhlRWc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--984edd0872f64017f45bace9c3630ec6fc7c4dc4/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Discover_NHL_092019v2_lock_up_2020.jpg?locale=us)
Americans are Delaying Non-Emergency Medical Care in Higher Numbers than Last Year
A national survey conducted by Discover Personal Loans has found that financial stress is impacting how Americans seek and pay for medical care.
As Americans find themselves living through a
![Coupon Rate of Subordinated Debt Securities to Qualified Investors](/assets/news/news4-fce0efe65d8ba787508ef718c0a20bed51e468dbc656c188c43e13f15b4a4f53.png)
Coupon Rate of Subordinated Debt Securities to Qualified Investors
![Rights and Issues Investment Trust PLC: Net Asset Value(s)](/assets/news/news8-29d1d55c755b03e328399113b5bdd004223f995e95194ba5ee80af9da39a41e3.png)
Rights and Issues Investment Trust PLC: Net Asset Value(s)
![Hardman & Co Research: Appreciate Group (APP) FY’22 results: going for growth](/assets/news/news7-ff65ae96e2a4b99929975e34f30f51b3393455f312fc86852d9fc8020c5054eb.png)
Hardman & Co Research: Appreciate Group (APP) FY’22 results: going for growth
![DGAP-Adhoc: tick Trading Software AG: Adjustment of the forecast for the financial year 2021/2022](/assets/news/news17-d49b9ce9c87babddea210274f0f8d00a1cf706146ef6382020cc7ece83b76f6c.png)
DGAP-Adhoc: tick Trading Software AG: Adjustment of the forecast for the financial year 2021/2022
![DGAP-Adhoc: Varengold Bank AG: Half-year result 2022 well above plan](/assets/news/news6-ad07925a95156ae03dbe17caf44a9dc29f254ff2c2a42c7678d35288ad55cec8.png)
DGAP-Adhoc: Varengold Bank AG: Half-year result 2022 well above plan
![DGAP-News: BIKE24 expands its climate protection activities and has again been confirmed as a climate-neutral company](/assets/news/news5-af8c677c86bb4b693f58afef33877e6f798ff0d7e2b4fa69b6e89960549b5ee6.png)
DGAP-News: BIKE24 expands its climate protection activities and has again been confirmed as a climate-neutral company
![Lysogene Provides Additional Update on AAVance Phase 2/3 Gene Therapy Clinical Trial with LYS-SAF302 in children with MPS IIIA: https://mms.businesswire.com/media/20220412005891/en/1418496/5/Lysogene_-_Logo.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBLzVLV0E9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--af42d7f7e3a0ce1ced09cf30a0eb36528a08e9c1/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Lysogene_-_Logo.jpg?locale=us)
Lysogene Provides Additional Update on AAVance Phase 2/3 Gene Therapy Clinical Trial with LYS-SAF302 in children with MPS IIIA
Regulatory News:
Lysogene (Paris:LYS)(FR0013233475 – LYS), a phase 3 gene therapy platform Company targeting central nervous system (CNS) diseases, today communicates additional preliminary data
![Baloise extends its partnership with FC Basel](/assets/news/news15-207f60e93f55a63563671c62b1e07d0bc426e50a03c286a608f29c8138f4f1de.png)
Baloise extends its partnership with FC Basel
![Fix Price announces the update on the Board of Directors](/assets/news/news14-e52b56a6adda780de8ab40d75cabe14dcfa77fc9676e986401297a29e68c991e.png)
Fix Price announces the update on the Board of Directors
![Sensorion to Present at the Gene Therapy Neurological Disorders Europe, CASSS Bioassays Symposium and Cell & Gene Therapy Summit Conferences in July 2022: https://mms.businesswire.com/media/20210609005851/en/705797/5/logo-sensorion2.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBK0dxVmc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--df3db62501cd2dac51e6a4832a420790d1de65b6/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/logo-sensorion2.jpg?locale=us)
Sensorion to Present at the Gene Therapy Neurological Disorders Europe, CASSS Bioassays Symposium and Cell & Gene Therapy Summit Conferences in July 2022
Regulatory News:
Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within
![Ørsted awarded contract for world’s single biggest offshore wind farm](/assets/news/news7-ff65ae96e2a4b99929975e34f30f51b3393455f312fc86852d9fc8020c5054eb.png)
Ørsted awarded contract for world’s single biggest offshore wind farm
![DGAP-News: IBU-tec advanced materials AG Concludes Agreements with International Raw Material Suppliers to Ensure Sustainable Materials Procurement](/assets/news/news6-ad07925a95156ae03dbe17caf44a9dc29f254ff2c2a42c7678d35288ad55cec8.png)
DGAP-News: IBU-tec advanced materials AG Concludes Agreements with International Raw Material Suppliers to Ensure Sustainable Materials Procurement
![Samarkand Group plc : Trading Update](/assets/news/news18-f135f6c168ef56d2b112890081403b0a310104acfadbf4a8f72634bd390e98ac.png)
Samarkand Group plc : Trading Update
![Cairn Homes Plc: Transaction in Own Shares](/assets/news/news14-e52b56a6adda780de8ab40d75cabe14dcfa77fc9676e986401297a29e68c991e.png)
Cairn Homes Plc: Transaction in Own Shares
![DGAP-News: SUSE S.A.: The Supervisory Board of SUSE S.A. nominates Sheng Liang to the Supervisory Board, replacing Matteo Thun](/assets/news/news16-82a218458f0e15ae617f9186b258dfd3add112716106c6ee3cbb48563ccdef52.png)
DGAP-News: SUSE S.A.: The Supervisory Board of SUSE S.A. nominates Sheng Liang to the Supervisory Board, replacing Matteo Thun
![Spexis' CXCR4 inhibitor balixafortide demonstrates synergistic efficacy in combination with docetaxel in a metastatic prostate cancer preclinical model](/assets/news/news9-b4ba75b613b80e3d047ded18f34335e7f81348578b67aee3f1469440916c031e.png)
Spexis' CXCR4 inhibitor balixafortide demonstrates synergistic efficacy in combination with docetaxel in a metastatic prostate cancer preclinical model
![DGAP-News: SUSE S.A.: Q2 Results Demonstrate the Strength of SUSE’s Mission-Critical Subscription Business](/assets/news/news8-29d1d55c755b03e328399113b5bdd004223f995e95194ba5ee80af9da39a41e3.png)
DGAP-News: SUSE S.A.: Q2 Results Demonstrate the Strength of SUSE’s Mission-Critical Subscription Business
![DGAP-News: Northern Data reports on operations for June 2022](/assets/news/news7-ff65ae96e2a4b99929975e34f30f51b3393455f312fc86852d9fc8020c5054eb.png)